Phase II study of R-CHOP followed by Y-90-ibritumomab tiuxetan in untreated mantle cell lymphoma: Eastern cooperative oncology group study E1499 49th Annual Meeting of the American-Society-of-Hematology Smith, M. R., Zhang, L., Gordon, L. I., Foran, J., Kahl, B., Gascoyne, R. D., Advani, R., Paietta, E., Weller, E., Horning, S. J. AMER SOC HEMATOLOGY. 2007: 121A–121A

View details for Web of Science ID 000251100800390